Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Investing Activities: 2023-2025

Historic Cash from Investing Activities for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $48.2 million.

  • Upstream Bio's Cash from Investing Activities rose 3319.87% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$110.5 million, marking a year-over-year decrease of 3.64%. This contributed to the annual value of -$59.5 million for FY2024, which is 28.19% up from last year.
  • Per Upstream Bio's latest filing, its Cash from Investing Activities stood at $48.2 million for Q3 2025, which was up 277.25% from $12.8 million recorded in Q2 2025.
  • Upstream Bio's 5-year Cash from Investing Activities high stood at $48.2 million for Q3 2025, and its period low was -$213.4 million during Q1 2025.
  • Its 3-year average for Cash from Investing Activities is -$27.1 million, with a median of $7.1 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Upstream Bio's Cash from Investing Activities was 3,319.87% (2025), while the steepest drop was 1,640.43% (2025).
  • Over the past 3 years, Upstream Bio's Cash from Investing Activities (Quarterly) stood at -$5.2 million in 2023, then spiked by 899.47% to $41.9 million in 2024, then soared by 3,319.87% to $48.2 million in 2025.
  • Its Cash from Investing Activities stands at $48.2 million for Q3 2025, versus $12.8 million for Q2 2025 and -$213.4 million for Q1 2025.